In an in vitro PD model, AS inhibited the decrease in PI3K expression induced by rotenone, eliminating ROT-induced abnormal neuronal dynamics at the synapse, thus affecting PI3K/Akt and thus activating the cytoprotective pathway to treat PD (Gopi et al., 2017). This evidence concerns the gene AKT1 and Parkinson disease.